Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2006
06/08/2006WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
06/08/2006WO2006059103A2 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products
06/08/2006WO2006058752A1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases
06/08/2006WO2006058628A2 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes
06/08/2006WO2006058546A1 Novel lactame derivatives as renin inhibitors
06/08/2006WO2006040451A3 Novel 9h-pyrido[2,3-b]indole derivatives serving as cdk and gsk3 inhibitors, method for the preparation thereof, and the pharmaceutical compositions containing such compounds
06/08/2006WO2006027474A3 Novel imidazopyridine derivatives having an affinity with respect to melatonin receptors, method for the preparation thereof and pharmaceutical compositions containing said derivatives
06/08/2006WO2006019940A3 Pyrrolo(oxo)quinolines as 5ht ligands
06/08/2006WO2005120505A3 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
06/08/2006WO2003077857A3 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
06/08/2006US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient
06/08/2006US20060122390 Boronic ester and acid compounds, synthesis and uses
06/08/2006US20060122245 Novel inhibitors of IMPDH enzyme
06/08/2006US20060122224 Quinoline and quinoxaline compounds
06/08/2006US20060122216 The enantiomer of tenatoprazole and the use thereof in therapy
06/08/2006US20060122215 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-C]pyridine derivatives for the treatment of obesity
06/08/2006US20060122213 Azaindoles useful as inhibitors of protein kinases
06/08/2006US20060122212 Bicyclic heteroaromatic compounds as kinase inhibitors
06/08/2006US20060122211 HIV integrase inhibitors, pharmaceutical compositions and methods for their use
06/08/2006US20060122210 Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same
06/08/2006US20060122185 Bicyclic inhibitors of Rho kinase
06/08/2006US20060122172 Novel 1,4-diazabicycloalkane derivatives, their preparation and use
06/08/2006US20060122171 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases
06/08/2006US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide
06/08/2006US20060122061 Arylphenyl-substituted cyclic ketoenols
06/08/2006US20060121308 High luminance, a high external quantum efficiency and a long high temperature driving life at 50 degrees C.; illuminator
06/08/2006CA2610347A1 Alpha-carbolines as cdk-1 inhibitors
06/08/2006CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
06/08/2006CA2587524A1 Substituted benzoquinolizine derivates
06/08/2006CA2586796A1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases
06/07/2006EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents.
06/07/2006EP1666477A1 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) q uinolonecarboxylic acid derivative
06/07/2006EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system
06/07/2006EP1664112A2 Chimeric gabab receptor
06/07/2006EP1664088A2 Hemiasterlin derivatives and uses thereof
06/07/2006EP1664048A2 Process for the preparation of renzapride and intermediates thereof
06/07/2006EP1664047A1 Substituted indolizine 1,2,3,6,7,8 derivatives, fgfs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives
06/07/2006EP1664046A1 Aza-quinolinol phosphonate integrase inhibitor compounds
06/07/2006EP1664045A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors
06/07/2006EP1664044A1 S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor
06/07/2006EP1664043A2 Compositions useful as inhibitors of protein kinases
06/07/2006EP1664042A1 IMIDAZO 1,5-a PYRIDINE OR IMIDAZO 1,5-a PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS
06/07/2006EP1664036A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity
06/07/2006EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
06/07/2006EP1664023A1 Sustituted isoquinoline derivatives and methods of use
06/07/2006EP1663994A1 Condensed pyrimidine compounds as inhibitors of voltage-gated ion channels
06/07/2006EP1663975A1 Novel gamma secretase inhibitors
06/07/2006EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
06/07/2006EP1663953A1 Inhibitors of histone deacetylase
06/07/2006EP1663238A1 HEXA- AND OCTAHYDRO-PYRIDO[1,2-a] PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY
06/07/2006EP1663237A2 Fused ring heterocycles as potassium channel modulators
06/07/2006EP1663227A2 Dihydropyridine compounds for treating or preventing metabolic disorders
06/07/2006EP1663223A2 Thalidomide analogs as tnf-alpha modulators
06/07/2006EP1663219A2 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
06/07/2006EP1663204A2 C-kit modulators and methods of use
06/07/2006EP1663202A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
06/07/2006EP1663184A2 Hydantoin derivatives as inhibitors of cellular necrosis
06/07/2006EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient
06/07/2006EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines
06/07/2006EP1286993B1 Imidazopyridin-8-ones
06/07/2006EP1259489B1 Aryl fused azapolycyclic compounds
06/07/2006EP1164202B1 Mismatch-recognizing molecules
06/07/2006CN1784409A Fused pyrimidine derivatives with CRF activity
06/07/2006CN1784404A Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
06/07/2006CN1784403A Azaindole compounds as kinase inhibitors
06/07/2006CN1784402A Imidazo and thiazolopyridines as JAK3 kinase inhibitors
06/07/2006CN1784401A Novel fused triazolones and the uses thereof
06/07/2006CN1784397A Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists
06/07/2006CN1784396A P38 inhibitors and methods of use thereof
06/07/2006CN1784380A Novel bioisosteres of actinonin
06/07/2006CN1784231A 1-amino 1H-imidazoquinolines
06/07/2006CN1258533C Antihistaminic spiro compounds
06/07/2006CN1258531C Aminomethyl pyrrolidine derivatives having aromatic substituents
06/06/2006US7057047 reacting 2-diaminopyridine with malic/sulfuric acid to form 2-amino-7-hydroxy-1,8-naphthyridine sulfuric acid salt, reacting in solvent to form phthalimidyl naphthyridine, chlorinating, reducing to hydroxyindolinone, then reacting with 5-methyl-2-oxo-hexyltriphenylphosphonium halide to form racemate
06/06/2006US7057046 Lactam glycogen phosphorylase inhibitors and method of use
06/06/2006US7057042 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
06/06/2006US7057039 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I
06/06/2006US7056944 Pyrazole compositions useful as inhibitors of erk
06/06/2006US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists
06/06/2006US7056917 Prevent drug resistance
06/06/2006US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria
06/06/2006US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc.
06/06/2006CA2277951C Imino-aza-anthracyclinone derivatives
06/06/2006CA2199468C 1,2,3,4-tetrahydroquinoxalinedione derivative
06/06/2006CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor
06/06/2006CA2160366C Risperidone pamoate
06/06/2006CA2145514C Process for the preparation of 9-amino camptothecin
06/01/2006WO2006058303A2 Modulators of muscarinic receptors
06/01/2006WO2006058080A1 Treatment of inflammatory bowel disease
06/01/2006WO2006058064A2 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/01/2006WO2006057983A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
06/01/2006WO2006057270A1 Nitrogeneous tricyclic compound
06/01/2006WO2006056863A1 Pyrido’2, 3-d!pyrimidines as anti-inflammatory agents
06/01/2006WO2006056696A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
06/01/2006WO2006056108A1 Nitromethylene derivatives and their use
06/01/2006WO2006056081A1 Method for preparing hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-one esters
06/01/2006WO2006038923A3 Aryl substituted imidazonaphthyridines
06/01/2006WO2006031929A3 Thiazolopyridine kinase inhibitors
06/01/2006WO2006005725A3 N containing condensed heterocycles with antitumor effects
06/01/2006WO2005095399A3 Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors